Literature DB >> 16007190

HNF4alpha reduces proliferation of kidney cells and affects genes deregulated in renal cell carcinoma.

Belén Lucas1, Karen Grigo, Silke Erdmann, Jörn Lausen, Ludger Klein-Hitpass, Gerhart U Ryffel.   

Abstract

Hepatocyte nuclear factor 4alpha (HNF4alpha) is a tissue-specific transcription factor known to regulate a large number of genes in hepatocytes and pancreatic beta cells. Although HNF4alpha is highly expressed in some sections of the kidney, little is known about its role in this organ and about HNF4alpha-regulated genes in the kidney cells. The abundance and activity of HNF4alpha are frequently reduced in renal cell carcinoma (RCC) indicating some tumor suppressing function of HNF4alpha in renal cells. To determine the potential role of HNF4alpha in RCC, we used Flp recombinase-mediated gene integration to generate human embryonic kidney cells (HEK293) that conditionally express wild-type or mutated HNF4alpha. Expression of wild-type HNF4alpha but not of the mutants led to reduction of proliferation and alterations of cell morphology. These effects were reversible and induced at physiological concentrations of HNF4alpha. Using gene expression profiling by microarrays, we determined genes regulated by HNF4alpha. Interestingly, many of the genes regulated by HNF4alpha have been shown to be deregulated in RCC microarray studies. These genes (ACY1, WT1, SELENBP1, COBL, EFHD1, AGXT2L1, ALDH5A1, THEM2, ABCB1, FLJ14146, CSPG2, TRIM9 and HEY1) are good candidates for genes whose activity is changed upon the decrease of HNF4alpha in RCC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16007190     DOI: 10.1038/sj.onc.1208794

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  45 in total

1.  Differential transcriptomic analysis of spontaneous lung tumors in B6C3F1 mice: comparison to human non-small cell lung cancer.

Authors:  Arun R Pandiri; Robert C Sills; Vincent Ziglioli; Thai-Vu T Ton; Hue-Hua L Hong; Stephanie A Lahousse; Kevin E Gerrish; Scott S Auerbach; Keith R Shockley; Pierre R Bushel; Shyamal D Peddada; Mark J Hoenerhoff
Journal:  Toxicol Pathol       Date:  2012-06-11       Impact factor: 1.902

2.  GATA4 loss of function in liver cancer impedes precursor to hepatocyte transition.

Authors:  Francis O Enane; Wai Ho Shuen; Xiaorong Gu; Ebrahem Quteba; Bartlomiej Przychodzen; Hideki Makishima; Juraj Bodo; Joanna Ng; Chit Lai Chee; Rebecca Ba; Lip Seng Koh; Janice Lim; Rachael Cheong; Marissa Teo; Zhenbo Hu; Kwok Peng Ng; Jaroslaw Maciejewski; Tomas Radivoyevitch; Alexander Chung; London Lucien Ooi; Yu Meng Tan; Peng-Chung Cheow; Pierce Chow; Chung Yip Chan; Kiat Hon Lim; Lisa Yerian; Eric Hsi; Han Chong Toh; Yogen Saunthararajah
Journal:  J Clin Invest       Date:  2017-07-31       Impact factor: 14.808

3.  Impairment of hepatic nuclear factor-4α binding to the Stim1 promoter contributes to high glucose-induced upregulation of STIM1 expression in glomerular mesangial cells.

Authors:  Yanxia Wang; Sarika Chaudhari; Yuezhong Ren; Rong Ma
Journal:  Am J Physiol Renal Physiol       Date:  2015-03-18

Review 4.  An integrative functional genomics approach for discovering biomarkers in schizophrenia.

Authors:  Marquis P Vawter; Firoza Mamdani; Fabio Macciardi
Journal:  Brief Funct Genomics       Date:  2011-12-08       Impact factor: 4.241

5.  Mdm2 is a novel activator of ApoCIII promoter which is antagonized by p53 and SHP inhibition.

Authors:  Zhihong Yang; Yuxia Zhang; Li Wang
Journal:  Biochem Biophys Res Commun       Date:  2011-12-16       Impact factor: 3.575

6.  The mechanisms of human hotdog-fold thioesterase 2 (hTHEM2) substrate recognition and catalysis illuminated by a structure and function based analysis.

Authors:  Jian Cao; Hang Xu; Hong Zhao; Weimin Gong; Debra Dunaway-Mariano
Journal:  Biochemistry       Date:  2009-02-17       Impact factor: 3.162

7.  Selenoprotein P regulation by the glucocorticoid receptor.

Authors:  Colleen Rock; Philip J Moos
Journal:  Biometals       Date:  2009-12       Impact factor: 2.949

8.  Nuclear receptor hepatocyte nuclear factor 4alpha1 competes with oncoprotein c-Myc for control of the p21/WAF1 promoter.

Authors:  Wendy W Hwang-Verslues; Frances M Sladek
Journal:  Mol Endocrinol       Date:  2007-09-20

9.  Dissection of the transformation of primary human hematopoietic cells by the oncogene NUP98-HOXA9.

Authors:  Enas R Yassin; Nayan J Sarma; Anmaar M Abdul-Nabi; James Dombrowski; Ye Han; Akiko Takeda; Nabeel R Yaseen
Journal:  PLoS One       Date:  2009-08-21       Impact factor: 3.240

10.  Improved conditional expression systems resulting in physiological level of HNF4alpha expression confirm HNF4alpha induced apoptosis in the pancreatic beta-cell line INS-1.

Authors:  Sabine Senkel; Christoph Waldner; Gerhart U Ryffel; Heike Thomas
Journal:  BMC Res Notes       Date:  2009-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.